APO RESEARCH · REPORT
Autism Spectrum Disorder Diagnosis and Therapeutics
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
Product & engineering
Understand the product.
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
Selected research
Industry Research
Autism Spectrum Disorder Diagnosis and Therapeutics Industry Research Report 2026
Market perspective
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
Global Autism Spectrum Disorder Diagnosis and Therapeutics key players include Otsuka, AstraZeneca, Pfizer, etc. Global top three manufacturers hold a share about 10%.
Europe is the largest market, with a share about 30%, followed by United States and China, both have a share about 45 percent.
Read the full market overview
In terms of product, Autistic Disorder is the largest segment, with a share about 35%. And in terms of application, the largest application is Children and Teenagers, followed by Adults.
Report Scope
This report quantifies the global Autism Spectrum Disorder Diagnosis and Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Autism Spectrum Disorder Diagnosis and Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Autism Spectrum Disorder Diagnosis and Therapeutics Market by Company
Otsuka
AstraZeneca
Pfizer
Eli Lilly
Johnson & Johnson
Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Type
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others
Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Application
Children and Teenagers
Adults
Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder Diagnosis and Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder Diagnosis and Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder Diagnosis and Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Autism Spectrum Disorder Diagnosis and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Autistic Disorder
- Asperger Syndrome
- Childhood Disintegrative Disorder
- Others
Applications
- Children and Teenagers
- Adults
Companies covered
- Otsuka
- AstraZeneca
- Pfizer
- Eli Lilly
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Autism Spectrum Disorder Diagnosis and Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Autistic Disorder
- 2.2.3 Asperger Syndrome
- 2.2.4 Childhood Disintegrative Disorder
- 2.2.5 Others
- 2.3 Autism Spectrum Disorder Diagnosis and Therapeutics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Children and Teenagers
- 2.3.3 Adults
- 2.4 Assumptions and Limitations
3 Autism Spectrum Disorder Diagnosis and Therapeutics Breakdown Data by Type
- 3.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Forecasted Market Size by Type (2027-2032)
4 Autism Spectrum Disorder Diagnosis and Therapeutics Breakdown Data by Application
- 4.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Historic Market Size by Application (2021-2026)
- 4.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Perspective (2021-2032)
- 5.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Growth Trends by Region
- 5.2.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Autism Spectrum Disorder Diagnosis and Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Autism Spectrum Disorder Diagnosis and Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Autism Spectrum Disorder Diagnosis and Therapeutics Market Dynamics
- 5.3.1 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Trends
- 5.3.2 Autism Spectrum Disorder Diagnosis and Therapeutics Market Drivers
- 5.3.3 Autism Spectrum Disorder Diagnosis and Therapeutics Market Challenges
- 5.3.4 Autism Spectrum Disorder Diagnosis and Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Autism Spectrum Disorder Diagnosis and Therapeutics Players by Revenue
- 6.1.1 Global Top Autism Spectrum Disorder Diagnosis and Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Autism Spectrum Disorder Diagnosis and Therapeutics Head Office and Area Served
- 6.4 Global Autism Spectrum Disorder Diagnosis and Therapeutics Players, Product Type & Application
- 6.5 Global Autism Spectrum Disorder Diagnosis and Therapeutics Manufacturers Established Date
- 6.6 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (2021-2032)
- 7.2 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (2021-2032)
- 8.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (2021-2032)
- 10.2 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Otsuka
- 12.1.1 Otsuka Company Information
- 12.1.2 Otsuka Business Overview
- 12.1.3 Otsuka Revenue in Autism Spectrum Disorder Diagnosis and Therapeutics Business (2021-2026)
- 12.1.4 Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 12.1.5 Otsuka Recent Developments
- 12.2 AstraZeneca
- 12.2.1 AstraZeneca Company Information
- 12.2.2 AstraZeneca Business Overview
- 12.2.3 AstraZeneca Revenue in Autism Spectrum Disorder Diagnosis and Therapeutics Business (2021-2026)
- 12.2.4 AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 12.2.5 AstraZeneca Recent Developments
- 12.3 Pfizer
- 12.3.1 Pfizer Company Information
- 12.3.2 Pfizer Business Overview
- 12.3.3 Pfizer Revenue in Autism Spectrum Disorder Diagnosis and Therapeutics Business (2021-2026)
- 12.3.4 Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 12.3.5 Pfizer Recent Developments
- 12.4 Eli Lilly
- 12.4.1 Eli Lilly Company Information
- 12.4.2 Eli Lilly Business Overview
- 12.4.3 Eli Lilly Revenue in Autism Spectrum Disorder Diagnosis and Therapeutics Business (2021-2026)
- 12.4.4 Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 12.4.5 Eli Lilly Recent Developments
- 12.5 Johnson & Johnson
- 12.5.1 Johnson & Johnson Company Information
- 12.5.2 Johnson & Johnson Business Overview
- 12.5.3 Johnson & Johnson Revenue in Autism Spectrum Disorder Diagnosis and Therapeutics Business (2021-2026)
- 12.5.4 Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 12.5.5 Johnson & Johnson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst